Antitumor effects of sunitinib or sorafenib in patients with metastatic renal cell carcinoma who received prior antiangiogenic therapy. - Tamaskar,I.; Garcia,J.A.; Elson,P.; Wood,L.; Mekhail,T.; Dreicer,R.; Rini,B.I.; Bukowski,R.M. (J Urol, 2008)